SEARCH

SEARCH BY CITATION

In the abstract of Papatheodoridis (1), the following statement is incorrect:

All NUCs are potent anti-hepatitis B virus agents (all except adefovir are more potent than IFN-α) with entecavir and tenofovir being the most potent. Most importantly NUCs all have minimal risk of resistance during long-term monotherapy.

The correct sentence should be:

All NUCs are potent anti-hepatitis B virus agents (all but adefovir are more potent than IFN-α) with entecavir (ETV) and tenofovir offering the highest potency and most importantly minimal to negligible risk of resistance during long-term monotherapy.

Reference

  1. Top of page
  2. Reference